Trial intelligence / Profile preview

Pediatric safety study of controlled-release oxycodone tablets

2010-020471-23Phase 3Completed

Sponsor
Purdue Pharma
Start
Aug 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of oxycodone in pain and cancer pain, sponsored by Purdue Pharma. Primary endpoint: Safety analysis. Started Aug 2010; status: completed.

02

Drugs

oxycodone
03

Conditions

paincancer pain

Beyond the preview

Go deeper on 2010-020471-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-020471-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call